Pierre Sayad - Mar 28, 2025 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role: Chief Medical Officer
Signature: /s/ Pierre Sayad
Stock symbol: FENC
Transactions as of: Mar 28, 2025
Transactions value $: $0
Form type: 4
Date filed: 4/3/2025, 07:15 PM
Previous filing: Nov 13, 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FENC	Restricted Share Unit	Award	$0	+10K	+6.67%	$0.00	160K	Mar 28, 2025	Common Shares	10K	$0.00	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 28, 2025, Pierre Sayad was awarded restricted share units to acquire 10,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan.
F2	One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction.

Content

On March 28, 2025, Pierre Sayad was awarded restricted share units to acquire 10,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan.

One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction.